📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin. (2016)

First Author: Tawar RG

Attributed to: AniMAb: Establishing a monoclonal antibody platform to interrogate animal antibody responses to inform rational design of veterinary vaccines funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hep.28767

PubMed Identifier: 27531416

Publication URI: http://europepmc.org/abstract/MED/27531416

Type: Journal Article/Review

Volume: 64

Parent Publication: Hepatology (Baltimore, Md.)

Issue: 5

ISSN: 0270-9139